Recent News

• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference 2025
• 09.08.2025 - New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
• 09.08.2025 - New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
• 09.03.2025 - Cantor Global Healthcare Conference 2025
• 08.29.2025 - Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
• 08.29.2025 - Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
• 07.31.2025 - Amicus Second Quarter 2025 Results Conference Call and Webcast
• 07.31.2025 - Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
• 07.31.2025 - Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
• 07.21.2025 - Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025

Recent Filings

• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.31.2025 - EX-99.1 EX-99.1
• 07.31.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2025 - 8-K Current report
• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities